This activity is hosted on the site of our educational partner

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

You will be connecting to our educational partner, which controls its own content, practices, and other policies.

  • Overview
  • Pre-Assessment
  • Activity
  • Post-Test
  • Evaluation
  • Claim Credit
Early Diagnosis and Individualized Management of IPF: Strategies for Shared Decision-Making to Improve Outcomes

Early Diagnosis and Individualized Management of IPF: Strategies for Shared Decision-Making to Improve Outcomes

Format

Webcast

Time to Complete

1 hour

Released

December 20, 2016

Expires

December 20, 2017
Add to Queue


Maximum Credits

1.00 / AMA PRA Category 1 CreditTM

Accredited Provider

Jointly provided by the Potomac Center for Medical Education and Rockpointe

Commercial Supporter

This activity is supported by an independent educational grant from Boehringer Ingelheim Pharmaceuticals, Inc.

Program Description

Guidelines for idiopathic pulmonary fibrosis (IPF) management were created in 2011 and updated in 2015 by a Joint Committee of the American Thoracic Society (ATS) and European, Japanese, and Latin American societies; however, wide variability remains in the management of IPF. Many clinicians have difficulty developing and implementing cross-functional multidisciplinary team initiatives and enhancing communication among health care providers. In order to improve health outcomes for patients with IPF, this program will review proven IPF diagnosis and management strategies to enable pulmonary units to perform a critical assessment of current practices and identify barriers to optimal outcomes, following examples from the Pulmonary Fibrosis Foundation (PFF) and the recently established PFF Care Center Network.

Intended Audience

This activity is intended for pulmonologists, allergists, immunologists, hospitalists, respiratory therapists, rheumatologist, internists, radiologists, pathologists, NPs, PAs, nurses, and other health professionals who are part of the multidisciplinary care team for patients with IPF.

Educational Objectives

At the conclusion of this activity, participants should be able to demonstrate the ability to:

  • Identify patients presenting with signs and risk factors of IPF and refer for HRCT to confirm diagnosis earlier in disease progression
  • Incorporate the most recent guidelines to develop an individualized management plan for each IPF patient, considering comorbidities, preferences, needs, and resources
  • Describe strategies to facilitate a multidisciplinary care team approach, including shared decision-making through provider-patient communication on symptom control, side-effect management, and therapy adherence

Fee Information

There is no fee for this activity.

Conflict Of Interest Disclosure Policy

Potomac Center for Medical Education (PCME) adheres to the policies and guidelines, including the Standards for Commercial Support, set forth to providers by the Accreditation Council for Continuing Medical Education (ACCME) and all other professional organizations, as applicable, stating those activities where continuing education credits are awarded must be balanced, independent, objective, and scientifically rigorous.

All persons in a position to control the content of a continuing medical education program provided by PCME are required to disclose any relevant financial relationships with any commercial interest to PCME as well as to learners. All conflicts of interest are identified and resolved by PCME in accordance with the Standards for Commercial Support in advance of delivery of the activity to learners.

The content of this activity was vetted by an external medical reviewer to assure objectivity and that the activity is free of commercial bias.

Faculty

Steven Nathan, MD
Medical Director Advanced Lung Disease & Transplant Program Inova Fairfax Hospital Professor of Medicine, Virginia Commonwealth University-Inova Fairfax campus
Falls Church, VA

Dr. Nathan discloses the following:
Consultant/Independent Contractor: Boehringer Ingelheim, Roche-Genentech, Gilead Sciences, United Therapeutics, Bayer Pharmaceuticals
Grant/Research: Boehringer Ingelheim, Roche-Genentech, Gilead Sciences, United Therapeutics, Bayer Pharmaceuticals
Honoraria: Boehringer Ingelheim, Roche-Genentech, Gilead Sciences, United Therapeutics, Bayer Pharmaceuticals
Speaker's Bureau: Boehringer Ingelheim, Roche-Genentech, Gilead Sciences, United Therapeutics, Bayer Pharmaceuticals

Leann L. Silhan, MD
Assistant Professor
Division Director of Education
Division of Pulmonary and Critical Care Medicine
Department of Medicine
Johns Hopkins University School of Medicine
Baltimore, MD

Dr. Silhan discloses the following:
Consultant/Independent Contractor: Boehringer Ingelheim

Accredited Provider Disclosure

The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

Jeanelle Spencer, PhD, Carole Drexel, PhD, CHCP, Blair St. Amand, Jay Katz, MA, CHCP, and Ashley Marostica, RN, MSN, have nothing to disclose.

Credit

1.00

Type

AMA PRA Category 1 Credit(s)TM

Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Potomac Center for Medical Education and Rockpointe. The Potomac Center for Medical Education is accredited by the ACCME to provide continuing medical education for physicians.

Designation Statement

The Potomac Center for Medical Education designates this enduring activity for a maximum of 1.00 AMA PRA Category I CreditTM. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Disclosure of Unlabeled Use

The contents of some CME/CE activities may contain discussions of non-approved or off-label uses of some agents mentioned. Please consult the prescribing information for full disclosure of approved uses.

Instructions

To obtain credit, a score of 80% or better on the post-test is required. This activity is offered at no cost to participants. Please proceed with the activity until you have successfully completed this program, answered all test questions, completed the post-test and evaluation, and have received a digital copy of your credit certificate. Your online certificate will be saved on myCME within your Profile/Exam History, which you can access at any time.

For questions regarding CME credit, the post-test, or evaluation, please email contact@potomacme.org.

If you have any questions relating to the accreditation of this activity, please email contact@potomacme.org.

If you have any other questions relating to your certificate or other issues with the activity, please contact myCME.Support@haymarketmedical.com.

SYSTEM REQUIREMENTS

Hardware and Software Requirements
  • A computer with an internet connection
  • Internet Browser: Internet Explorer 7.x or higher, Firefox 4.x or higher, Safari 2.x or higher, or any other W3C standards compliant browser
  • Additional Software: Adobe Flash Player and/or an HTML 5 capable browser maybe required for video or audio playback. PowerPoint or Adobe Acrobat Reader may occasionally be required
Add to Queue